Avery Dennison expands pharmaceutical portfolio with syringe labeling products
Avery Dennison (averydennison.com) has introduced a line of new syringe labeling products to its pharmaceutical portfolio. The portfolio extension features safe, compliant label stock solutions, which meet manufacturers’ high standards for syringe and tight mandrel pharmaceutical applications.
“According to the IMS Institute for Healthcare Informatics, the global pharmaceutical segment is projected to grow to more than $1 trillion by 2018, with focused growth in the oncology, diabetes, pain and autoimmune therapy areas,” said David Collins, marketing director, specialty, Avery Dennison Label and Packaging Materials - North America.